KMTS KMTS Costs Of Revenue — Depreciation

Similar metrics at other companies

AHCODepreciation and amortization, excluding patient equipment depreciation

$10.1M-3.0%

KEE

KEELDepreciation And Amortization — Cost Of Revenue

$27.69M+50.1%

TALKCost Of Revenue Excluding Depreciation And Amortization

$36.06M+25.3%

TTIDepreciation, amortization and accretion

$9.18M+0.3%

ABTMedical Devices — Depreciation

$100M+13.6%

EVTCCost of revenues, exclusive of depreciation and amortization

$118.25M+3.2%

Questions, answered.

What is KMTS's costs of revenue — depreciation?

KMTS (KMTS) reported costs of revenue — depreciation of $705K in Q4 2025.

How has KMTS's costs of revenue — depreciation changed year-over-year?

KMTS's costs of revenue — depreciation increased by 133.4% year-over-year, from $302K to $705K.

What does costs of revenue — depreciation mean?

This metric represents the portion of depreciation expense directly attributable to the assets used in the production or delivery of the company's wearable medical devices and digital healthcare services. It reflects the systematic allocation of the cost of manufacturing equipment and monitoring infrastructure over their useful lives as part of the direct cost of revenue. Monitoring this expense helps investors understand the capital intensity required to support the company's commercial-stage operations and service delivery platform.